Senior insider sale
Chief Financial Officer at RHYTHM PHARMACEUTICALS, INC. — senior position signals high conviction
$351.6K
3.25K shares
What this filing means
SMITH HUNTER C plans to sell 3.25K shares of RHYTHM PHARMACEUTICALS, INC. valued at approximately $351.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 2/4/2026ACC: 0001950047-26-000924
Officer· Chief Financial Officer
Since Mar 2026
3.25K
Shares to sell
$351.6K
Approx. market value
3.25K
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Restricted Stock Units
N/A
2/3/2025
3.25KTotal acquired3.25K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/3/2025 | Restricted Stock Units N/A | 3.25K | — |
| Total | 3.25K | ||
Planned & Completed Dispositions1
NASDAQPlanned
Units to sell
3.25K
Market value
$351.6K
2/4/2026
Total
Units
3.25K
Value
$351.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
2/4/2026 | 3.25K | $351.6K | NASDAQ | Planned |
| Total | 3.25K | $351.6K | ||